• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 1990-2019 年卒中负担的时间趋势和可归因危险因素:2019 年全球疾病负担研究分析。

Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019.

机构信息

Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.

出版信息

Lancet Public Health. 2021 Dec;6(12):e897-e906. doi: 10.1016/S2468-2667(21)00228-0.

DOI:10.1016/S2468-2667(21)00228-0
PMID:34838196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9047702/
Abstract

BACKGROUND

Understanding the temporal trend of the disease burden of stroke and its attributable risk factors in China, especially at provincial levels, is important for effective prevention strategies and improvement. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) is to investigate the disease burden of stroke and its risk factors at national and provincial levels in China from 1990 to 2019.

METHODS

Following the methodology in the GBD 2019, the incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) of stroke cases in the Chinese population were estimated by sex, age, year, stroke subtypes (ischaemic stroke, intracerebral haemorrhage, and subarachnoid haemorrhage), and across 33 provincial administrative units in China from 1990 to 2019. Attributable mortality and DALYs of underlying risk factors were calculated by a comparative risk assessment.

FINDINGS

In 2019, there were 3·94 million (95% uncertainty interval 3·43-4·58) new stroke cases in China. The incidence rate of stroke increased by 86·0% (73·2-99·0) from 1990, reaching 276·7 (241·3-322·0) per 100 000 population in 2019. The age-standardised incidence rate declined by 9·3% (3·3-15·5) from 1990 to 2019. Among 28·76 million (25·60-32·21) prevalent cases of stroke in 2019, 24·18 million (20·80-27·87) were ischaemic stroke, 4·36 million (3·69-5·05) were intracerebral haemorrhage, and 1·58 million (1·32-1·91) were subarachnoid haemorrhage. The prevalence rate increased by 106·0% (93·7-118·8) and age-standardised prevalence rate increased by 13·2% (7·7-19·1) from 1990 to 2019. In 2019, there were 2·19 million (1·89-2·51) deaths and 45·9 million (39·8-52·3) DALYs due to stroke. The mortality rate increased by 32·3% (8·6-59·0) from 1990 to 2019. Over the same period, the age-standardised mortality rate decreased by 39·8% (28·6-50·7) and the DALY rate decreased by 41·6% (30·7-50·9). High systolic blood pressure, ambient particulate matter pollution exposure, smoking, and diet high in sodium were four major risk factors for stroke burden in 2019. Moreover, we found marked differences of stroke burden and attributable risk factors across provinces in China from 1990 to 2019.

INTERPRETATION

The disease burden of stroke is still severe in China, although the age-standardised incidence and mortality rates have decreased since 1990. The stroke burden in China might be reduced through blood pressure management, lifestyle interventions, and air pollution control. Moreover, because substantial heterogeneity of stroke burden existed in different provinces, improved health care is needed in provinces with heavy stroke burden.

FUNDING

National Key Research and Development Program of China and Taikang Yicai Public Health and Epidemic Control Fund.

摘要

背景

了解中国脑卒中疾病负担及其归因风险因素的时间趋势,特别是在省级层面,对于制定有效的预防策略和改善措施非常重要。本研究旨在利用全球疾病、伤害和风险因素研究(GBD)的方法,调查中国脑卒中的疾病负担及其在国家和省级层面的风险因素。

方法

根据 GBD 2019 的方法,我们估计了中国 1990 年至 2019 年期间的脑卒中发病率、患病率、死亡率和伤残调整生命年(DALYs),并按性别、年龄、年份、脑卒中亚型(缺血性脑卒中、颅内出血和蛛网膜下腔出血)和中国 33 个省级行政区进行了分类。通过比较风险评估,计算了潜在风险因素的归因死亡率和 DALYs。

结果

2019 年,中国有 394 万(95%不确定性区间为 343 万至 458 万)新发脑卒中病例。1990 年以来,脑卒中的发病率增加了 86.0%(73.2-99.0),2019 年达到每 10 万人 276.7 例(241.3-322.0)。1990 年至 2019 年,年龄标准化发病率下降了 9.3%(3.3-15.5)。在 2019 年 2876 万例脑卒中患者中,2418 万例(2080 万至 2787 万例)为缺血性脑卒中,436 万例(369 万至 505 万例)为颅内出血,158 万例(132 万至 191 万例)为蛛网膜下腔出血。1990 年至 2019 年,患病率增加了 106.0%(93.7-118.8),年龄标准化患病率增加了 13.2%(7.7-19.1)。2019 年,有 219 万人(189 万至 251 万)死于脑卒中,4590 万人(3980 万至 5230 万)患有脑卒中伤残调整生命年(DALYs)。1990 年至 2019 年,死亡率增加了 32.3%(8.6-59.0)。同期,年龄标准化死亡率下降了 39.8%(28.6-50.7),DALY 率下降了 41.6%(30.7-50.9)。高收缩压、环境颗粒物污染暴露、吸烟和高钠饮食是 2019 年脑卒中负担的四个主要风险因素。此外,我们发现,1990 年至 2019 年期间,中国各省份脑卒中负担及其归因风险因素存在显著差异。

结论

尽管自 1990 年以来,中国脑卒中的年龄标准化发病率和死亡率有所下降,但脑卒中的疾病负担仍然很严重。通过血压管理、生活方式干预和控制空气污染,可能会降低中国的脑卒中负担。此外,由于不同省份脑卒中负担存在显著差异,因此需要在脑卒中负担较重的省份加强卫生保健。

资金

国家重点研发计划和泰康溢彩公共卫生与流行病防控基金。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebe5/9047702/d7663e5a4139/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebe5/9047702/3e55994d4042/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebe5/9047702/d7663e5a4139/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebe5/9047702/3e55994d4042/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebe5/9047702/d7663e5a4139/gr2.jpg

相似文献

1
Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019.中国 1990-2019 年卒中负担的时间趋势和可归因危险因素:2019 年全球疾病负担研究分析。
Lancet Public Health. 2021 Dec;6(12):e897-e906. doi: 10.1016/S2468-2667(21)00228-0.
2
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990—2019年全球、区域和国家的卒中负担及其风险因素:全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
3
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家的卒中负担及其风险因素,1990-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7.
4
The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990-2017: an analysis for the Global Burden of Disease Study 2017.空气污染对中国及其省份 1990-2017 年死亡、疾病负担和预期寿命的影响:2017 年全球疾病负担研究分析。
Lancet Planet Health. 2020 Sep;4(9):e386-e398. doi: 10.1016/S2542-5196(20)30161-3. Epub 2020 Aug 17.
5
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.
6
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家卒中负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 May;18(5):439-458. doi: 10.1016/S1474-4422(19)30034-1. Epub 2019 Mar 11.
7
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年食管痛的全球、区域和国家负担及其可归因风险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1.
8
Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017.全球、区域和国家特定缺血性卒中、脑出血和蛛网膜下腔出血负担:2017 年全球疾病负担研究的系统分析。
Neuroepidemiology. 2020;54(2):171-179. doi: 10.1159/000506396. Epub 2020 Feb 20.
9
The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study.中国 2005-2018 年因高收缩压导致的心血管疾病负担:基于人群的研究。
Lancet Public Health. 2022 Dec;7(12):e1027-e1040. doi: 10.1016/S2468-2667(22)00232-8.
10
Burden of falls among people aged 60 years and older in mainland China, 1990-2019: findings from the Global Burden of Disease Study 2019.中国内地 60 岁及以上人群跌倒负担:2019 年全球疾病负担研究结果。
Lancet Public Health. 2021 Dec;6(12):e907-e918. doi: 10.1016/S2468-2667(21)00231-0.

引用本文的文献

1
G20 stroke burden 1990-2035: trends, projections and precision health insights.1990 - 2035年二十国集团的中风负担:趋势、预测与精准健康见解
Neurol Sci. 2025 Sep 8. doi: 10.1007/s10072-025-08465-4.
2
Sarcopenia index based on serum creatinine and cystatin C is associated with the risk of stroke in middle-aged and older adults in Chinese: a prospective cohort study from the China health and retirement longitudinal study.基于血清肌酐和胱抑素C的肌少症指数与中国中老年人群的中风风险相关:一项来自中国健康与养老追踪调查的前瞻性队列研究
BMC Neurol. 2025 Sep 1;25(1):371. doi: 10.1186/s12883-025-04327-w.
3
Effectiveness of intermittent theta burst stimulation (iTBS) on Post-Stroke motor dysfunction: A Meta-Analysis of randomized controlled trials.

本文引用的文献

1
Changes in Life Expectancy of Respiratory Diseases from Attaining Daily PM Standard in China: A Nationwide Observational Study.中国实现每日PM标准后呼吸系统疾病预期寿命的变化:一项全国性观察研究。
Innovation (Camb). 2020 Nov 4;1(3):100064. doi: 10.1016/j.xinn.2020.100064. eCollection 2020 Nov 25.
2
Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019.1990 年至 2019 年中国视力丧失的患病率和病因:2019 年全球疾病负担研究的结果。
Lancet Public Health. 2020 Dec;5(12):e682-e691. doi: 10.1016/S2468-2667(20)30254-1.
3
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
间歇性theta波爆发刺激(iTBS)对中风后运动功能障碍的疗效:一项随机对照试验的荟萃分析。
Neurol Sci. 2025 Aug 30. doi: 10.1007/s10072-025-08441-y.
4
Comparing burden of ischemic stroke caused by high low-density lipoprotein cholesterol in global and China: trends and projections.全球及中国高低密度脂蛋白胆固醇所致缺血性卒中负担比较:趋势与预测
Front Neurol. 2025 Aug 13;16:1622361. doi: 10.3389/fneur.2025.1622361. eCollection 2025.
5
Barriers and facilitators for stroke patients' adherence to rehabilitation in China: a qualitative study based on medical experts.中国脑卒中患者康复依从性的障碍与促进因素:一项基于医学专家的定性研究
Sci Rep. 2025 Aug 27;15(1):31525. doi: 10.1038/s41598-025-12795-w.
6
Post-traumatic growth in young and middle-aged patients with stroke: a qualitative systematic review and meta-synthesis.中青年脑卒中患者的创伤后成长:一项定性系统评价与元整合分析
BMC Psychol. 2025 Aug 26;13(1):967. doi: 10.1186/s40359-025-03321-8.
7
Exploring the Association Between Cerebellar Regional Volumes and Health-Related Quality of Life in Patients with Ischemic Stroke: A Prospective Cohort Study.探索缺血性中风患者小脑区域体积与健康相关生活质量之间的关联:一项前瞻性队列研究。
Cerebellum. 2025 Aug 14;24(5):143. doi: 10.1007/s12311-025-01889-w.
8
Qizhi Jieyu Pill for the Treatment of Cerebral Infarction During the Recovery Phase: Protocol for a Randomized Controlled Clinical Trial.芪蛭解郁丸治疗脑梗死恢复期:一项随机对照临床试验方案
JMIR Res Protoc. 2025 Aug 13;14:e75982. doi: 10.2196/75982.
9
Temporal trends and epidemiological impact of metabolic risk factors on stroke burden in Chinese individuals aged 65 and older, 1992-2021.1992 - 2021年中国65岁及以上人群中代谢危险因素对卒中负担的时间趋势及流行病学影响
Front Neurol. 2025 Jul 29;16:1607823. doi: 10.3389/fneur.2025.1607823. eCollection 2025.
10
Fear of progression profiles and their association with quality of life and depression in ischemic stroke survivors: a latent profile analysis.缺血性中风幸存者的疾病进展恐惧概况及其与生活质量和抑郁的关联:一项潜在概况分析
BMC Psychiatry. 2025 Aug 12;25(1):780. doi: 10.1186/s12888-025-07242-z.
204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
4
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
5
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1950-2019 年全球年龄性别特定生育率、死亡率、健康期望寿命(HALE)和人口估计值:2019 年全球疾病负担研究的综合人口分析。
Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6.
6
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks.21 世纪中国老龄化研究议程(第二版):关注基础和转化研究、长期护理、政策和社会网络。
Ageing Res Rev. 2020 Dec;64:101174. doi: 10.1016/j.arr.2020.101174. Epub 2020 Sep 21.
7
Secular trends of stroke incidence and mortality in China, 1990 to 2016: The Global Burden of Disease Study 2016.中国 1990 至 2016 年的卒中发病率和死亡率的变化趋势:2016 年全球疾病负担研究。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104959. doi: 10.1016/j.jstrokecerebrovasdis.2020.104959. Epub 2020 Jun 2.
8
Global Stroke Statistics 2019.全球中风统计 2019.
Int J Stroke. 2020 Oct;15(8):819-838. doi: 10.1177/1747493020909545. Epub 2020 Mar 9.
9
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017.2017 年全球儿童和青少年癌症负担:基于 2017 年全球疾病负担研究的分析。
Lancet Oncol. 2019 Sep;20(9):1211-1225. doi: 10.1016/S1470-2045(19)30339-0. Epub 2019 Jul 29.
10
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.